CTMX - CytomX Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

CTMX is currently covered by 9 analysts with an average price target of $12.78. This is a potential upside of $10.75 (529.56%) from yesterday's end of day stock price of $2.03.

CytomX Therapeutics's activity chart (see below) currently has 100 price targets and 99 ratings on display. The stock rating distribution of CTMX is 94.12% BUY and 5.88% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 32.53% of the time, taking 123.28 days on average.

Highest price target for CTMX is $16, Lowest price target is $10, average price target is $12.78.

Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 12-Nov-2026. First documented stock forecast 02-Nov-2015.

Currently out of the existing stock ratings of CTMX, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 13-Aug-2026

$12

$9.97 (491.13%)

$11

10 days ago
(12-Nov-2026)

0/5 (0%)

$9.96 (488.24%)

Buy Since 17-Mar-2026

$12

$9.97 (491.13%)

$11

16 days ago
(06-Nov-2026)

2/6 (33.33%)

$9.81 (447.95%)

87

Buy Since 09-Mar-2026

$14

$11.97 (589.66%)

$15

3 months 12 days ago
(10-Aug-2026)

0/4 (0%)

$10.56 (306.98%)

Buy Since 20-May-2025

$11

$8.97 (441.87%)

$10

6 months 11 days ago
(11-May-2026)

2/4 (50%)

$7.14 (184.97%)

244

Buy Since 10-Nov-2025

$12

$9.97 (491.13%)

$10

7 months 30 days ago
(23-Mar-2026)

1/3 (33.33%)

$7.54 (169.06%)

126

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CTMX (CytomX Therapeutics) average time for price targets to be met?

On average it took 123 days for the stock forecasts to be reached, with an average price target met ratio of 32.53%.

Which analyst most recently updated their price target on CTMX (CytomX Therapeutics)?

Anupam Rama

Which analyst has the most public recommendations on CTMX (CytomX Therapeutics)?

Anupam Rama works at JPMORGAN and has 36 price targets and 21 ratings on CTMX

Which analyst is the currently most bullish on CTMX (CytomX Therapeutics)?

Varun Kumar with the highest potential upside of $20.97

Which analyst is the currently most reserved on CTMX (CytomX Therapeutics)?

Mara Goldstein with the lowest potential downside of -$0.03
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?